标题
Cardiovascular Risks and Benefits of Medications Used for Weight Loss
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-01-15
DOI
10.3389/fendo.2019.00883
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
- (2019) Monica Bolton et al. BMC Medicine
- Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
- (2019) Xu Zhao et al. BMC Endocrine Disorders
- Safety and Effectiveness of Longer‐Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort
- (2019) Kristina H. Lewis et al. Obesity
- Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity
- (2019) Nicholas T. Bello Expert Opinion On Drug Safety
- Short-Term Evidence in Adults of Anorexigenic Drugs Acting in the Central Nervous System: A Meta-Analysis
- (2019) Daniela Farah et al. CLINICAL THERAPEUTICS
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate
- (2019) Shamir N. Kalaria et al. CTS-Clinical and Translational Science
- Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers
- (2018) Neal L. Benowitz et al. JAMA Internal Medicine
- Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study
- (2018) Niina Matikainen et al. DIABETES OBESITY & METABOLISM
- Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
- (2018) Erin A. Bohula et al. NEW ENGLAND JOURNAL OF MEDICINE
- Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder
- (2017) Susan L. McElroy et al. INTERNATIONAL JOURNAL OF EATING DISORDERS
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder
- (2017) James I. Hudson et al. JAMA Psychiatry
- Fiber supplements and clinically proven health benefits
- (2017) Kellen V. Lambeau et al. Journal of the American Association of Nurse Practitioners
- Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential
- (2017) Michael E. Røder Therapeutic Advances in Chronic Disease
- Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial
- (2016) Olivia M. Farr et al. DIABETES
- Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
- (2016) Preman Kumarathurai et al. DIABETES CARE
- GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
- (2016) Olivia M. Farr et al. DIABETOLOGIA
- Effect of phentermine on weight reduction in a pediatric weight management clinic
- (2016) J R Ryder et al. INTERNATIONAL JOURNAL OF OBESITY
- The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy
- (2016) K Fujioka et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular Effects of the New Weight Loss Agents
- (2016) Matthew H. Vorsanger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study
- (2015) Takashi Kadowaki et al. ADVANCES IN THERAPY
- Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis
- (2015) Feng Sun et al. CLINICAL THERAPEUTICS
- Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial
- (2015) S. Ross et al. DIABETES OBESITY & METABOLISM
- Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
- (2015) R. Chilton et al. DIABETES OBESITY & METABOLISM
- Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
- (2015) Feng Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity
- (2015) Susan Z. Yanovski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
- (2015) Juan Pablo Domecq et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
- (2014) David ZI Cherney et al. Cardiovascular Diabetology
- A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
- (2014) David R. Coghill et al. CNS DRUGS
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardiovascular effects of phentermine and topiramate
- (2014) Jens Jordan et al. JOURNAL OF HYPERTENSION
- Safety and Efficacy of Lorcaserin: A Combined Analysis of the BLOOM and BLOSSOM Trials
- (2014) Louis Aronne et al. POSTGRADUATE MEDICINE
- Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- (2013) Erin S. LeBlanc et al. ANNALS OF INTERNAL MEDICINE
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
- (2013) R. A. DeFronzo et al. DIABETES CARE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- A comparative study of five centrally acting drugs on the pharmacological treatment of obesity
- (2013) H Suplicy et al. INTERNATIONAL JOURNAL OF OBESITY
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Phentermine and topiramate for the management of obesity: a review
- (2013) Gabriel Uwaifo et al. Drug Design Development and Therapy
- Leptin reverses declines in satiation in weight-reduced obese humans
- (2012) Harry R Kissileff et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Zonisamide for Weight Reduction in Obese Adults
- (2012) Kishore M. Gadde et al. ARCHIVES OF INTERNAL MEDICINE
- Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis
- (2012) J. Plutzky et al. Canadian Journal of Diabetes
- Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials
- (2012) Rémy Boussageon et al. PLOS MEDICINE
- Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes
- (2011) B. Mittendorfer et al. DIABETES
- Sibutramine on Cardiovascular Outcome
- (2011) A. J. Scheen DIABETES CARE
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial
- (2011) M. A. Nauck et al. DIABETES CARE
- Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet
- (2011) Greeshma K Shetty et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Novel strategy for the use of leptin for obesity therapy
- (2011) Charmaine S Tam et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity
- (2011) Ed J. Hendricks et al. Obesity
- Ten years of leptin replacement therapy
- (2011) G. Paz-Filho et al. Obesity Reviews
- Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic–Induced Weight Gain
- (2010) Lara K Ellinger et al. ANNALS OF PHARMACOTHERAPY
- Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
- (2010) J. G. Kang et al. DIABETES OBESITY & METABOLISM
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects
- (2009) C Cercato et al. INTERNATIONAL JOURNAL OF OBESITY
- Methylphenidate Has Positive Hypocholesterolemic and Hypotriglyceridemic Effects: New Data
- (2009) Gideon Charach et al. JOURNAL OF CLINICAL PHARMACOLOGY
- How Physician Obesity Specialists Use Drugs to Treat Obesity
- (2009) Ed J. Hendricks et al. Obesity
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Sustained-Release Bupropion on Blood Pressure in Individuals With Mild Untreated Hypertension
- (2008) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now